HCA Healthcare, Inc.
HCA
$531.47
$29.425.86%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 75.60B | 74.37B | 72.70B | 71.59B | 70.60B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 75.60B | 74.37B | 72.70B | 71.59B | 70.60B |
| Cost of Revenue | 44.23B | 43.60B | 42.97B | 42.31B | 41.93B |
| Gross Profit | 31.37B | 30.77B | 29.73B | 29.28B | 28.68B |
| SG&A Expenses | 1.03B | 1.05B | 1.05B | 1.05B | 1.05B |
| Depreciation & Amortization | 3.52B | 3.47B | 3.42B | 3.38B | 3.31B |
| Other Operating Expenses | 14.86B | 14.62B | 14.18B | 14.01B | 13.77B |
| Total Operating Expenses | 63.64B | 62.74B | 61.62B | 60.74B | 60.06B |
| Operating Income | 11.97B | 11.63B | 11.08B | 10.84B | 10.55B |
| Income Before Tax | 9.83B | 9.29B | 8.78B | 8.60B | 8.52B |
| Income Tax Expenses | 2.05B | 1.99B | 1.90B | 1.92B | 1.87B |
| Earnings from Continuing Operations | 7.78K | 7.31K | 6.88K | 6.68K | 6.66K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -998.00M | -961.00M | -913.00M | -901.00M | -897.00M |
| Net Income | 6.78B | 6.34B | 5.97B | 5.78B | 5.76B |
| EBIT | 11.97B | 11.63B | 11.08B | 10.84B | 10.55B |
| EBITDA | 15.49B | 15.10B | 14.50B | 14.22B | 13.86B |
| EPS Basic | 28.63 | 26.12 | 24.01 | 22.69 | 22.19 |
| Normalized Basic EPS | 21.61 | 20.45 | 18.89 | 18.03 | 17.05 |
| EPS Diluted | 28.38 | 25.87 | 23.79 | 22.49 | 21.97 |
| Normalized Diluted EPS | 21.42 | 20.26 | 18.73 | 17.88 | 16.90 |
| Average Basic Shares Outstanding | 949.71M | 974.31M | 998.18M | 1.02B | 1.04B |
| Average Diluted Shares Outstanding | 958.24M | 982.84M | 1.01B | 1.03B | 1.05B |
| Dividend Per Share | 2.88 | 2.82 | 2.76 | 2.70 | 2.64 |
| Payout Ratio | 10.01% | 10.75% | 11.47% | 11.85% | 11.98% |